The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication.

Frois C, O'Connell T, Pesa J, Fastenau J

DOI: 10.36469/9853
Published: 2013
Container: Journal of health economics and outcomes research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.36469/9853,
  title = {The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication.},
  author = {Frois C and O'Connell T and Pesa J and Fastenau J},
  year = {2013},
  journal = {Journal of health economics and outcomes research},
  doi = {10.36469/9853},
  url = {https://doi.org/10.36469/9853}
}

RIS

TY  - JOUR
TI  - The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication.
AU  - Frois C
AU  - O'Connell T
AU  - Pesa J
AU  - Fastenau J
PY  - 2013
JO  - Journal of health economics and outcomes research
DO  - 10.36469/9853
UR  - https://doi.org/10.36469/9853
ER  -

APA

C, F., T, O., J, P., & J, F. (2013). The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication.. Journal of health economics and outcomes research. https://doi.org/10.36469/9853

Source records

pubmed · retrieved 2026-09-26T15:38:43.925Z